Ostrowski, Mario
St. Michael's Hospital · University of Toronto · Unity Health Toronto · Keenan Research Centre for Biomedical Science
9 papers on CoChatORCID 0000-0002-7369-1936
Most cited papers
- Verified
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Isho, B., Abe, K. T., Zuo, M., Jamal, A. J., Rathod, B., Wang, J. H., Li, Z., Chao, G., Rojas, O. L., Bang, Y. M., et al. (2020) · Science Immunology
SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing
Cited by 822
- Verified
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
Huang, Y.-H., Zhu, C., Kondo, Y., Anderson, A. C., Gandhi, A., Russell, A., Dougan, S. K., Petersen, B.-S., Melum, E., Pertel, T., et al. (2015) · Nature
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 717
- Verified
TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection
Chew, G. M., Fujita, T., Webb, G. M., Burwitz, B. J., Wu, H. L., Reed, J. S., Hammond, K. B., Clayton, K. L., Ishii, N., Abdel-Mohsen, M., et al. (2016) · PLoS Pathogens
HIV Research and TreatmentT-cell and B-cell Immunology
Cited by 323
- Verified
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Chun, T.-W., Justement, J. S., Murray, D., Hallahan, C. W., Maenza, J., Collier, A. C., Sheth, P. M., Kaul, R., Ostrowski, M., Moir, S., et al. (2010) · AIDS
HIV Research and TreatmentHIV/AIDS drug development and treatment
Cited by 276
- Verified
T Cell Ig and Mucin Domain–Containing Protein 3 Is Recruited to the Immune Synapse, Disrupts Stable Synapse Formation, and Associates with Receptor Phosphatases
Clayton, K. L., Haaland, M. S., Douglas-Vail, M. B., Mujib, S., Chew, G. M., Ndhlovu, L. C., & Ostrowski, M. A. (2014) · The Journal of Immunology
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 134
- Verified
T Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection
Garrison, K. E., Jones, R. B., Meiklejohn, D. A., Anwar, N., Ndhlovu, L. C., Chapman, J. M., Erickson, A. L., Agrawal, A., Spotts, G., Hecht, F. M., et al. (2007) · PLoS Pathogens
HIV Research and TreatmentT-cell and B-cell Immunology
Cited by 131
- Verified
Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition
Jones, R. B., Garrison, K. E., Wong, J. C., Duan, E. H., Nixon, D. F., & Ostrowski, M. A. (2008) · PLoS ONE
Chromosomal and Genetic VariationsHIV/AIDS drug development and treatment
Cited by 99
- Verified
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Liu, J., Budylowski, P., Samson, R., Griffin, B. D., Babuadze, G., Rathod, B., Colwill, K., Abioye, J. A., Schwartz, J. A., Law, R., et al. (2022) · Science Advances
SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing
Cited by 56
- Verified
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
Abe, K. T., Hu, Q., Mozafarihashjin, M., Samson, R., Manguiat, K., Robinson, A., Rathod, B., Hardy, W. R., Wang, J. H., Iskilova, M., et al. (2021) · medRxiv
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 32
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free